BlackRock Health Sciences Term Trust Announces Monthly Dividend of $0.09 (NYSE:BMEZ)

BlackRock Health Sciences Term Trust (NYSE:BMEZGet Free Report) announced a monthly dividend on Monday, April 1st, Zacks reports. Investors of record on Monday, April 15th will be given a dividend of 0.09 per share on Tuesday, April 30th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 6.79%. The ex-dividend date is Friday, April 12th.

BlackRock Health Sciences Term Trust has increased its dividend by an average of 16.5% per year over the last three years.

BlackRock Health Sciences Term Trust Stock Down 0.1 %

NYSE:BMEZ traded down 0.01 during mid-day trading on Wednesday, reaching 15.90. The company’s stock had a trading volume of 276,287 shares, compared to its average volume of 352,724. The company’s fifty day simple moving average is 16.04 and its two-hundred day simple moving average is 14.84. BlackRock Health Sciences Term Trust has a twelve month low of 12.93 and a twelve month high of 16.95.

Insider Activity at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. bought 72,085 shares of the firm’s stock in a transaction dated Thursday, January 11th. The stock was bought at an average price of 15.17 per share, for a total transaction of 1,093,529.45. Following the transaction, the insider now owns 16,858,923 shares in the company, valued at 255,749,861.91. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. In the last ninety days, insiders have purchased 2,196,942 shares of company stock worth $34,415,254.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Comerica Bank acquired a new stake in shares of BlackRock Health Sciences Term Trust during the third quarter worth $257,000. HBK Sorce Advisory LLC acquired a new position in BlackRock Health Sciences Term Trust in the 1st quarter worth about $251,000. B. Riley Wealth Advisors Inc. increased its holdings in shares of BlackRock Health Sciences Term Trust by 16.5% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 14,280 shares of the company’s stock valued at $239,000 after acquiring an additional 2,018 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of BlackRock Health Sciences Term Trust by 36.3% during the 2nd quarter. Envestnet Asset Management Inc. now owns 13,986 shares of the company’s stock valued at $230,000 after acquiring an additional 3,722 shares during the last quarter. Finally, Pathstone Holdings LLC acquired a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter valued at about $222,000.

BlackRock Health Sciences Term Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

See Also

Dividend History for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.